Immediate and One-Year Outcomes of an Asthma-Tailored Pulmonary Rehabilitation Programme in Overweight and Obese People with Difficult-to-Treat Asthma
Management of difficult-to-treat asthma is particularly challenging in people with elevated body mass index (BMI). Our randomised controlled trial of pulmonary rehabilitation (PR) showed improved outcomes at 8 weeks. Here we assess immediate and one-year effects of asthma-tailored PR in participants...
Saved in:
Published in | Journal of asthma and allergy Vol. 17; pp. 911 - 928 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New Zealand
Dove Medical Press Limited
01.01.2024
Dove Dove Medical Press |
Subjects | |
Online Access | Get full text |
ISSN | 1178-6965 1178-6965 |
DOI | 10.2147/JAA.S466894 |
Cover
Abstract | Management of difficult-to-treat asthma is particularly challenging in people with elevated body mass index (BMI). Our randomised controlled trial of pulmonary rehabilitation (PR) showed improved outcomes at 8 weeks. Here we assess immediate and one-year effects of asthma-tailored PR in participants with difficult-to-treat asthma and BMI ≥25 kg/m
, and identify response predictors.
A prospective observational study of PR, tailored to asthma, comparing outcomes at baseline (V1), immediately after 8 weeks of PR (V2), and at 1 year (V3). Baseline characteristics were compared in responders/non-responders defined by achievement of minimum clinically important difference (MCID) for asthma control questionnaire (ACQ6) (0.5) at 8 weeks and 1 year.
Of 92 participants, 56 attended V2 and 45 attended V3. Mean age was 60 (SD 13) years, 60% were female, and median (IQR) BMI was 33.8 (29.5-38.7) kg/m
. At V1, V2, and V3, respectively, there were significant differences in ACQ6 (mean (95% CI): 2.5 (2.1-2.9), 2.2 (1.8-2.5), and 2.3 (1.9-2.7),
<0.003), Borg breathlessness score post-6-minute walk test (median (IQR): 2 (0.5-3), 1 (0-2), and 1 (0.5-2),
<0.035), and annualised exacerbations requiring prednisolone (median (IQR): 3 (2-5), 0 (0-4.7), and 1.5 (0-4.2),
<0.003). A total of 27/56 (48%) had improvements >MCID for ACQ6 at V2 and 16 (33%) at V3. Participants with higher ACQ6 scores at baseline (suggesting poorer asthma control) were more likely to achieve MCID. Baseline BMI, within the range studied, was not predictive.
Pulmonary rehabilitation induced improvements in asthma-related outcomes including perception of breathlessness, asthma control, and exacerbation frequency at 1 year. Those with poorer baseline asthma control were more likely to benefit. |
---|---|
AbstractList | Management of difficult-to-treat asthma is particularly challenging in people with elevated body mass index (BMI). Our randomised controlled trial of pulmonary rehabilitation (PR) showed improved outcomes at 8 weeks. Here we assess immediate and one-year effects of asthma-tailored PR in participants with difficult-to-treat asthma and BMI ≥25 kg/m
, and identify response predictors.
A prospective observational study of PR, tailored to asthma, comparing outcomes at baseline (V1), immediately after 8 weeks of PR (V2), and at 1 year (V3). Baseline characteristics were compared in responders/non-responders defined by achievement of minimum clinically important difference (MCID) for asthma control questionnaire (ACQ6) (0.5) at 8 weeks and 1 year.
Of 92 participants, 56 attended V2 and 45 attended V3. Mean age was 60 (SD 13) years, 60% were female, and median (IQR) BMI was 33.8 (29.5-38.7) kg/m
. At V1, V2, and V3, respectively, there were significant differences in ACQ6 (mean (95% CI): 2.5 (2.1-2.9), 2.2 (1.8-2.5), and 2.3 (1.9-2.7),
<0.003), Borg breathlessness score post-6-minute walk test (median (IQR): 2 (0.5-3), 1 (0-2), and 1 (0.5-2),
<0.035), and annualised exacerbations requiring prednisolone (median (IQR): 3 (2-5), 0 (0-4.7), and 1.5 (0-4.2),
<0.003). A total of 27/56 (48%) had improvements >MCID for ACQ6 at V2 and 16 (33%) at V3. Participants with higher ACQ6 scores at baseline (suggesting poorer asthma control) were more likely to achieve MCID. Baseline BMI, within the range studied, was not predictive.
Pulmonary rehabilitation induced improvements in asthma-related outcomes including perception of breathlessness, asthma control, and exacerbation frequency at 1 year. Those with poorer baseline asthma control were more likely to benefit. Management of difficult-to-treat asthma is particularly challenging in people with elevated body mass index (BMI). Our randomised controlled trial of pulmonary rehabilitation (PR) showed improved outcomes at 8 weeks. Here we assess immediate and one-year effects of asthma-tailored PR in participants with difficult-to-treat asthma and BMI ≥25 kg/m2, and identify response predictors.IntroductionManagement of difficult-to-treat asthma is particularly challenging in people with elevated body mass index (BMI). Our randomised controlled trial of pulmonary rehabilitation (PR) showed improved outcomes at 8 weeks. Here we assess immediate and one-year effects of asthma-tailored PR in participants with difficult-to-treat asthma and BMI ≥25 kg/m2, and identify response predictors.A prospective observational study of PR, tailored to asthma, comparing outcomes at baseline (V1), immediately after 8 weeks of PR (V2), and at 1 year (V3). Baseline characteristics were compared in responders/non-responders defined by achievement of minimum clinically important difference (MCID) for asthma control questionnaire (ACQ6) (0.5) at 8 weeks and 1 year.MethodsA prospective observational study of PR, tailored to asthma, comparing outcomes at baseline (V1), immediately after 8 weeks of PR (V2), and at 1 year (V3). Baseline characteristics were compared in responders/non-responders defined by achievement of minimum clinically important difference (MCID) for asthma control questionnaire (ACQ6) (0.5) at 8 weeks and 1 year.Of 92 participants, 56 attended V2 and 45 attended V3. Mean age was 60 (SD 13) years, 60% were female, and median (IQR) BMI was 33.8 (29.5-38.7) kg/m2. At V1, V2, and V3, respectively, there were significant differences in ACQ6 (mean (95% CI): 2.5 (2.1-2.9), 2.2 (1.8-2.5), and 2.3 (1.9-2.7), p<0.003), Borg breathlessness score post-6-minute walk test (median (IQR): 2 (0.5-3), 1 (0-2), and 1 (0.5-2), p<0.035), and annualised exacerbations requiring prednisolone (median (IQR): 3 (2-5), 0 (0-4.7), and 1.5 (0-4.2), p<0.003). A total of 27/56 (48%) had improvements >MCID for ACQ6 at V2 and 16 (33%) at V3. Participants with higher ACQ6 scores at baseline (suggesting poorer asthma control) were more likely to achieve MCID. Baseline BMI, within the range studied, was not predictive.ResultsOf 92 participants, 56 attended V2 and 45 attended V3. Mean age was 60 (SD 13) years, 60% were female, and median (IQR) BMI was 33.8 (29.5-38.7) kg/m2. At V1, V2, and V3, respectively, there were significant differences in ACQ6 (mean (95% CI): 2.5 (2.1-2.9), 2.2 (1.8-2.5), and 2.3 (1.9-2.7), p<0.003), Borg breathlessness score post-6-minute walk test (median (IQR): 2 (0.5-3), 1 (0-2), and 1 (0.5-2), p<0.035), and annualised exacerbations requiring prednisolone (median (IQR): 3 (2-5), 0 (0-4.7), and 1.5 (0-4.2), p<0.003). A total of 27/56 (48%) had improvements >MCID for ACQ6 at V2 and 16 (33%) at V3. Participants with higher ACQ6 scores at baseline (suggesting poorer asthma control) were more likely to achieve MCID. Baseline BMI, within the range studied, was not predictive.Pulmonary rehabilitation induced improvements in asthma-related outcomes including perception of breathlessness, asthma control, and exacerbation frequency at 1 year. Those with poorer baseline asthma control were more likely to benefit.ConclusionPulmonary rehabilitation induced improvements in asthma-related outcomes including perception of breathlessness, asthma control, and exacerbation frequency at 1 year. Those with poorer baseline asthma control were more likely to benefit. Introduction: Management of difficult-to-treat asthma is particularly challenging in people with elevated body mass index (BMI). Our randomised controlled trial of pulmonary rehabilitation (PR) showed improved outcomes at 8 weeks. Here we assess immediate and one-year effects of asthma-tailored PR in participants with difficult-to-treat asthma and BMI [greater than or equal to]25 kg/[m.sup.2], and identify response predictors. Methods: A prospective observational study of PR, tailored to asthma, comparing outcomes at baseline (V1), immediately after 8 weeks of PR (V2), and at 1 year (V3). Baseline characteristics were compared in responders/non-responders defined by achievement of minimum clinically important difference (MCID) for asthma control questionnaire (ACQ6) (0.5) at 8 weeks and 1 year. Results: Of 92 participants, 56 attended V2 and 45 attended V3. Mean age was 60 (SD 13) years, 60% were female, and median (IQR) BMI was 33.8 (29.5-38.7) kg/[m.sup.2]. At V1, V2, and V3, respectively, there were significant differences in ACQ6 (mean (95% CI): 2.5 (2.1-2.9), 2.2 (1.8-2.5), and 2.3 (1.9-2.7), p<0.003), Borg breathlessness score post-6-minute walk test (median (IQR): 2 (0.5-3), 1 (0-2), and 1 (0.5-2), p<0.035), and annualised exacerbations requiring prednisolone (median (IQR): 3 (2-5), 0 (0-4.7), and 1.5 (0-4.2), p<0.003). A total of 27/56 (48%) had improvements >MCID for ACQ6 at V2 and 16 (33%) at V3. Participants with higher ACQ6 scores at baseline (suggesting poorer asthma control) were more likely to achieve MCID. Baseline BMI, within the range studied, was not predictive. Conclusion: Pulmonary rehabilitation induced improvements in asthma-related outcomes including perception of breathlessness, asthma control, and exacerbation frequency at 1 year. Those with poorer baseline asthma control were more likely to benefit. Keywords: asthma, difficult-to-treat asthma, obesity, pulmonary rehabilitation Helen Clare Ricketts,1 Varun Sharma,1 Femke Steffensen,2 Elaine Mackay,3 Gordon Wallace MacDonald,4 Duncan S Buchan,5 Michael Lean,6 Rekha Chaudhuri,7 Douglas C Cowan4 1College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK; 2Glasgow Clinical Research Facility, Glasgow Royal Infirmary, Glasgow, UK; 3Pulmonary Rehabilitation Team, Glasgow Royal Infirmary, Glasgow, UK; 4Respiratory Department, Glasgow Royal Infirmary, Glasgow, UK; 5Division of Sports and Exercise, University of the West of Scotland, Glasgow, UK; 6School of Medicine, Dentistry and Nursing, University of Glasgow, Glasgow, UK; 7Respiratory Department, Gartnavel General Hospital, Glasgow, UKCorrespondence: Douglas C Cowan, Email douglas.cowan@ggc.scot.nhs.ukIntroduction: Management of difficult-to-treat asthma is particularly challenging in people with elevated body mass index (BMI). Our randomised controlled trial of pulmonary rehabilitation (PR) showed improved outcomes at 8 weeks. Here we assess immediate and one-year effects of asthma-tailored PR in participants with difficult-to-treat asthma and BMI ≥ 25 kg/m2, and identify response predictors.Methods: A prospective observational study of PR, tailored to asthma, comparing outcomes at baseline (V1), immediately after 8 weeks of PR (V2), and at 1 year (V3). Baseline characteristics were compared in responders/non-responders defined by achievement of minimum clinically important difference (MCID) for asthma control questionnaire (ACQ6) (0.5) at 8 weeks and 1 year.Results: Of 92 participants, 56 attended V2 and 45 attended V3. Mean age was 60 (SD 13) years, 60% were female, and median (IQR) BMI was 33.8 (29.5– 38.7) kg/m2. At V1, V2, and V3, respectively, there were significant differences in ACQ6 (mean (95% CI): 2.5 (2.1– 2.9), 2.2 (1.8– 2.5), and 2.3 (1.9– 2.7), p< 0.003), Borg breathlessness score post-6-minute walk test (median (IQR): 2 (0.5– 3), 1 (0– 2), and 1 (0.5– 2), p< 0.035), and annualised exacerbations requiring prednisolone (median (IQR): 3 (2– 5), 0 (0– 4.7), and 1.5 (0– 4.2), p< 0.003). A total of 27/56 (48%) had improvements >MCID for ACQ6 at V2 and 16 (33%) at V3. Participants with higher ACQ6 scores at baseline (suggesting poorer asthma control) were more likely to achieve MCID. Baseline BMI, within the range studied, was not predictive.Conclusion: Pulmonary rehabilitation induced improvements in asthma-related outcomes including perception of breathlessness, asthma control, and exacerbation frequency at 1 year. Those with poorer baseline asthma control were more likely to benefit.Keywords: asthma, difficult-to-treat asthma, obesity, pulmonary rehabilitation |
Audience | Academic |
Author | Chaudhuri, Rekha Buchan, Duncan Mackay, Elaine Cowan, Douglas Steffensen, Femke Lean, Michael MacDonald, Gordon Sharma, Varun Ricketts, Helen |
Author_xml | – sequence: 1 givenname: Helen surname: Ricketts fullname: Ricketts, Helen – sequence: 2 givenname: Varun orcidid: 0000-0003-0183-3090 surname: Sharma fullname: Sharma, Varun – sequence: 3 givenname: Femke surname: Steffensen fullname: Steffensen, Femke – sequence: 4 givenname: Elaine surname: Mackay fullname: Mackay, Elaine – sequence: 5 givenname: Gordon surname: MacDonald fullname: MacDonald, Gordon – sequence: 6 givenname: Duncan surname: Buchan fullname: Buchan, Duncan – sequence: 7 givenname: Michael surname: Lean fullname: Lean, Michael – sequence: 8 givenname: Rekha surname: Chaudhuri fullname: Chaudhuri, Rekha – sequence: 9 givenname: Douglas orcidid: 0000-0001-7297-9041 surname: Cowan fullname: Cowan, Douglas |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39346093$$D View this record in MEDLINE/PubMed |
BookMark | eNptkk-L1DAYh4usuOu6J-8SEESQjkmTpulJhvXfyMIMOh48hTR9O82SNmOS7uIX8fOaccZlBkwPCcnzPu3b_J5mZ6MbIcueEzwrCKvefpnPZ98Y56Jmj7ILQiqR85qXZ0fr8-wqhFucBq05p_xJdk5ryjiu6UX2ezEM0BoVAamxRcsR8h-gPFpOUbsBAnJdOkDzEPtB5WtlrPPQotVkBzcq_wt9hV41xpqoonEjWnm38So5kRnR8g78PZhNH_fyBgKgFbitBXRvYo_em64zerIxjy5fe1Dx8KZn2eNO2QBXh_ky-_7xw_r6c36z_LS4nt_kusQs5pRophSvGqExobqsRVHqpiuxhpYzQcqmqCvBClx0WkBLmorjtuI1bilToCi9zBZ7b-vUrdx6M6SepFNG_t1wfiOVj0ZbkLyiotLAqgpzRlQpGK6ToSGkq7VuWHK927u2U5P-qYYxemVPpKcno-nlxt1JQli6kHJneH0wePdzghDlYIIGa9UIbgqSEkIKzAshEvpyj25U-jYzdi4p9Q6Xc0FoSShjdaJm_6HS08JgdEpSZ9L-ScGro4IelI19cHba3W04BV8cN_vQ5b9kJeDNHtDeheChe0AIlrvoyhRdeYgu_QP2_t8G |
Cites_doi | 10.1007/s11882-021-01024-9 10.1177/0269215519832942 10.1183/13993003.02058-2018 10.1164/rccm.200711-1754OC 10.1097/HCR.0000000000000249 10.1183/13993003.01820-2019 10.1007/s41030-023-00230-2 10.1136/thoraxjnl-2016-209130 10.1183/13993003.01359-2015 10.1136/thoraxjnl-2020-215168 10.1002/14651858.CD013485.pub2 10.3109/02770903.2014.996650 10.1164/rccm.201203-0573OC 10.1183/23120541.00309-2020 10.1186/s12890-022-02152-2 10.1164/rccm.201309-1634ST 10.1016/j.rmed.2019.08.015 10.1136/thorax.57.12.1028 10.1016/j.rmed.2004.10.008 10.1164/ajrccm.166.1.at1102 10.1016/j.rmed.2017.03.029 10.1136/thoraxjnl-2012-203103 10.1016/S0002-9343(00)00472-1 10.1164/rccm.201908-1590ST 10.1016/j.rmed.2007.06.031 10.1164/rccm.200906-0896OC 10.1002/14651858.CD001277.pub4 10.1016/j.rehab.2022.101691 10.1513/AnnalsATS.202111-1228OC 10.1152/ajpregu.00325.2022 10.1136/thoraxjnl-2013-203808 10.1378/chest.118.1.106 10.1164/rccm.9120-11ST 10.1093/ajcn/85.5.1197 10.1183/13993003.congress-2022.579 10.1249/MSS.0000000000001574 |
ContentType | Journal Article |
Copyright | 2024 Ricketts et al. COPYRIGHT 2024 Dove Medical Press Limited 2024 Ricketts et al. 2024 Ricketts et al. |
Copyright_xml | – notice: 2024 Ricketts et al. – notice: COPYRIGHT 2024 Dove Medical Press Limited – notice: 2024 Ricketts et al. 2024 Ricketts et al. |
DBID | AAYXX CITATION NPM 7X8 5PM DOA |
DOI | 10.2147/JAA.S466894 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | Ricketts et al |
EISSN | 1178-6965 |
EndPage | 928 |
ExternalDocumentID | oai_doaj_org_article_67387ce4770641a58409a33b11f9ccb4 PMC11439354 A813513449 39346093 10_2147_JAA_S466894 |
Genre | Journal Article |
GeographicLocations | United Kingdom |
GeographicLocations_xml | – name: United Kingdom |
GrantInformation_xml | – fundername: ; |
GroupedDBID | --- 0YH 29J 2WC 5VS 7RV 8C1 8FE 8FH 8FI 8FJ 8G5 AAYXX ABUWG ACGFO ADBBV ADRAZ AFKRA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BKEYQ BPHCQ BVXVI CCPQU CITATION DIK DWQXO E3Z EBD EBS EJD FYUFA GNUQQ GROUPED_DOAJ GUQSH GX1 HCIFZ HYE IAO IHR IHW IPNFZ ITC KQ8 LK8 M2O M48 M7P M~E NAPCQ O5R O5S OK1 P2P P6G PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC RIG RNS RPM TDBHL TR2 UKHRP VDV NPM PJZUB PPXIY PQGLB PMFND 7X8 PUEGO 5PM |
ID | FETCH-LOGICAL-c504t-31c4aa67b8c013c59825cbf50ced64815b29784202fc8ed1b760d7690d34aea33 |
IEDL.DBID | M48 |
ISSN | 1178-6965 |
IngestDate | Wed Aug 27 01:21:00 EDT 2025 Thu Aug 21 18:31:23 EDT 2025 Thu Sep 04 21:22:00 EDT 2025 Tue Jun 17 22:02:53 EDT 2025 Tue Jun 10 21:00:52 EDT 2025 Thu May 22 21:24:33 EDT 2025 Mon Jul 21 05:40:57 EDT 2025 Tue Jul 01 03:31:30 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | difficult-to-treat asthma asthma pulmonary rehabilitation obesity |
Language | English |
License | https://creativecommons.org/licenses/by-nc/3.0 2024 Ricketts et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c504t-31c4aa67b8c013c59825cbf50ced64815b29784202fc8ed1b760d7690d34aea33 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-0183-3090 0000-0001-7297-9041 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.2147/JAA.S466894 |
PMID | 39346093 |
PQID | 3111206288 |
PQPubID | 23479 |
PageCount | 18 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_67387ce4770641a58409a33b11f9ccb4 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11439354 proquest_miscellaneous_3111206288 gale_infotracmisc_A813513449 gale_infotracacademiconefile_A813513449 gale_healthsolutions_A813513449 pubmed_primary_39346093 crossref_primary_10_2147_JAA_S466894 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2024-01-01 |
PublicationDateYYYYMMDD | 2024-01-01 |
PublicationDate_xml | – month: 01 year: 2024 text: 2024-01-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | New Zealand |
PublicationPlace_xml | – name: New Zealand |
PublicationTitle | Journal of asthma and allergy |
PublicationTitleAlternate | J Asthma Allergy |
PublicationYear | 2024 |
Publisher | Dove Medical Press Limited Dove Dove Medical Press |
Publisher_xml | – name: Dove Medical Press Limited – name: Dove – name: Dove Medical Press |
References | Dweik (ref27) 2011; 184 Bolton (ref16) 2013; 68 Spruit (ref25) 2013; 188 McDonald (ref9) 2019; 53 ref2 Santino (ref36) 2020; 3 Lista-Paz (ref38) 2023; 66 ref1 Sideleva (ref4) 2012; 186 Freitas (ref21) 2018; 50 Osadnik (ref22) 2022; 8 Hernández (ref34) 2000; 118 Grosbois (ref31) 2019; 157 Moore (ref15) 2010; 181 Casey (ref33) 2013; 68 Sogard (ref39) 2023; 325 Boulet (ref6) 2007; 101 Hudler (ref13) 2023; 9 Troosters (ref35) 2000; 109 Jackson (ref10) 2021; 76 Haldar (ref14) 2008; 178 Agusti (ref8) 2016; 47 Mccarthy (ref17) 2015; 2015 Andreasson (ref37) 2022; 19 Umetsu (ref3) 2017; 72 Klein (ref30) 2007; 85 ref41 Chinn (ref5) 2002; 57 Türk (ref20) 2020; 56 Turk (ref19) 2017; 37 Graham (ref26) 2019; 200 Sharma (ref11) 2023; 60 Arden-Close (ref40) 2019; 33 Ricketts (ref23) 2022; 22 ref28 Sharma (ref7) 2021; 21 Juniper (ref29) 2005; 99 Mesquita (ref32) 2017; 126 Kyriakopoulos (ref12) 2021; 7 Lingner (ref24) 2015; 52 Sahin (ref18) 2019; 56 |
References_xml | – volume: 21 start-page: 46 year: 2021 ident: ref7 publication-title: Curr Allergy Asthma Rep doi: 10.1007/s11882-021-01024-9 – volume: 33 start-page: 1139 year: 2019 ident: ref40 publication-title: Clin Rehabil doi: 10.1177/0269215519832942 – ident: ref1 – volume: 53 start-page: 1802058 year: 2019 ident: ref9 publication-title: Eur Respir J doi: 10.1183/13993003.02058-2018 – volume: 178 start-page: 218 year: 2008 ident: ref14 publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.200711-1754OC – volume: 37 start-page: 214 year: 2017 ident: ref19 publication-title: J Cardiopulm Rehabil Prev doi: 10.1097/HCR.0000000000000249 – volume: 56 start-page: 1901820 year: 2020 ident: ref20 publication-title: Eur Respir J doi: 10.1183/13993003.01820-2019 – volume: 9 start-page: 309 year: 2023 ident: ref13 publication-title: Pulm Ther doi: 10.1007/s41030-023-00230-2 – volume: 72 start-page: 174 year: 2017 ident: ref3 publication-title: Thorax doi: 10.1136/thoraxjnl-2016-209130 – volume: 47 start-page: 410 year: 2016 ident: ref8 publication-title: Eur Respir J doi: 10.1183/13993003.01359-2015 – volume: 76 start-page: 220 year: 2021 ident: ref10 publication-title: Thorax doi: 10.1136/thoraxjnl-2020-215168 – volume: 8 start-page: 1 year: 2022 ident: ref22 publication-title: Cochrane Database Syst Rev doi: 10.1002/14651858.CD013485.pub2 – volume: 52 start-page: 614 year: 2015 ident: ref24 publication-title: J Asthma doi: 10.3109/02770903.2014.996650 – volume: 186 start-page: 598 year: 2012 ident: ref4 publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.201203-0573OC – volume: 7 start-page: 00309 year: 2021 ident: ref12 publication-title: ERJ Open Res doi: 10.1183/23120541.00309-2020 – volume: 22 start-page: 363 year: 2022 ident: ref23 publication-title: BMC Pulm Med doi: 10.1186/s12890-022-02152-2 – volume: 188 start-page: e13 year: 2013 ident: ref25 publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.201309-1634ST – volume: 157 start-page: 36 year: 2019 ident: ref31 publication-title: Respir Med doi: 10.1016/j.rmed.2019.08.015 – volume: 57 start-page: 1028 year: 2002 ident: ref5 publication-title: Thorax doi: 10.1136/thorax.57.12.1028 – volume: 99 start-page: 553 year: 2005 ident: ref29 publication-title: Respir Med doi: 10.1016/j.rmed.2004.10.008 – ident: ref28 doi: 10.1164/ajrccm.166.1.at1102 – volume: 2015 start-page: 1 year: 2015 ident: ref17 publication-title: Cochrane Database Syst Rev – ident: ref2 – volume: 126 start-page: 122 year: 2017 ident: ref32 publication-title: Respir Med doi: 10.1016/j.rmed.2017.03.029 – volume: 68 start-page: 922 year: 2013 ident: ref33 publication-title: Thorax doi: 10.1136/thoraxjnl-2012-203103 – volume: 56 start-page: 87 year: 2019 ident: ref18 publication-title: J Asthma off J Assoc Care Asthma – volume: 109 start-page: 207 year: 2000 ident: ref35 publication-title: Am J Med doi: 10.1016/S0002-9343(00)00472-1 – volume: 200 start-page: E70 year: 2019 ident: ref26 publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.201908-1590ST – volume: 101 start-page: 2240 year: 2007 ident: ref6 publication-title: Respir Med doi: 10.1016/j.rmed.2007.06.031 – volume: 181 start-page: 315 year: 2010 ident: ref15 publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.200906-0896OC – volume: 3 start-page: CD001277 year: 2020 ident: ref36 publication-title: Cochrane Database Syst Rev doi: 10.1002/14651858.CD001277.pub4 – volume: 66 start-page: 101691 year: 2023 ident: ref38 publication-title: Ann Phys Rehabil Med doi: 10.1016/j.rehab.2022.101691 – volume: 19 start-page: 1498 year: 2022 ident: ref37 publication-title: Ann Am Thorac Soc doi: 10.1513/AnnalsATS.202111-1228OC – volume: 325 start-page: R645 year: 2023 ident: ref39 publication-title: Am J Physiol-Regul Integr Comp Physiol doi: 10.1152/ajpregu.00325.2022 – volume: 68 start-page: 1 year: 2013 ident: ref16 publication-title: Thorax doi: 10.1136/thoraxjnl-2013-203808 – volume: 60 start-page: 385 year: 2023 ident: ref11 publication-title: J Asthma off J Assoc Care Asthma – volume: 118 start-page: 106 year: 2000 ident: ref34 publication-title: Chest doi: 10.1378/chest.118.1.106 – volume: 184 start-page: 602 year: 2011 ident: ref27 publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.9120-11ST – volume: 85 start-page: 1197 year: 2007 ident: ref30 publication-title: Am J Clin Nutr doi: 10.1093/ajcn/85.5.1197 – ident: ref41 doi: 10.1183/13993003.congress-2022.579 – volume: 50 start-page: 1367 year: 2018 ident: ref21 publication-title: Med Sci Sports Exerc doi: 10.1249/MSS.0000000000001574 |
SSID | ssj0000396636 |
Score | 2.279386 |
Snippet | Management of difficult-to-treat asthma is particularly challenging in people with elevated body mass index (BMI). Our randomised controlled trial of pulmonary... Introduction: Management of difficult-to-treat asthma is particularly challenging in people with elevated body mass index (BMI). Our randomised controlled... Helen Clare Ricketts,1 Varun Sharma,1 Femke Steffensen,2 Elaine Mackay,3 Gordon Wallace MacDonald,4 Duncan S Buchan,5 Michael Lean,6 Rekha Chaudhuri,7 Douglas... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 911 |
SubjectTerms | Asthma Body mass index Comparative analysis Corticosteroids difficult-to-treat asthma obesity Original Research Patient compliance Prednisolone pulmonary rehabilitation Rehabilitation |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LbxMxELZQDxUXRHkuLWCkSpyWbtb2Po5boCqVIBGkUjlZfqqRyKZqNof-EX4vM_Y2isWBC9f1KFn7G3tmvDPfEHLsDLde1EVelspCgOLhHBTe5sIIrU2jkI8Esy2-VeeX_OJKXO20-sKcsEgPHBfuBLtS1sbxugbjOVECAxLFmJ5MfGuMDkygRVvsBFPhDGbgxuN3SSzIw1Y8Jxdd9-EHr6qm5YkJCkz9f5_HOwYpTZbcsT5nj8mj0W2kXXzdA_LA9U_I_tfxw_hT8vvLMtSADI6q3tJp7_KfoMN0uhlApdyarjwM0G49XC9VPlcLCNOdpbPNL1BDdXtHvyeM3XQW07aWji56Og3J0xjFxx_Xbu3oLKSeU7zHpZ_w4gc5PPJhlc_RDR3_6Rm5PPs8_3iejy0XciMKPsCJbLhSVa0bA76hQXY_YbQXhXG2Ql4XXULYycui9KZxdqLrqrA1RNiWceUAl-dkr1_17iWhADIzpS8bJTz4ZLDwdVlpkGkrz1vjM3J8j4K8icwaEiISBEsCWHIEKyOniNBWBOmwwwNQEjkqifyXkmTkLeIrY23pdlPLrsEGhYzzNiPvgwRua4DZqLE6AeaCBFmJ5FEiCdvRJMPv7nVI4hDmsPVutVlLBmalDO2dM_Ii6tR2VqxlvCpalpEm0bZk2ulIv7gObOAQ0GJ5NX_1PxbqkDwEbHm8Yzoie8Ptxr0Gr2vQb8IG-wOhDio4 priority: 102 providerName: Directory of Open Access Journals |
Title | Immediate and One-Year Outcomes of an Asthma-Tailored Pulmonary Rehabilitation Programme in Overweight and Obese People with Difficult-to-Treat Asthma |
URI | https://www.ncbi.nlm.nih.gov/pubmed/39346093 https://www.proquest.com/docview/3111206288 https://pubmed.ncbi.nlm.nih.gov/PMC11439354 https://doaj.org/article/67387ce4770641a58409a33b11f9ccb4 |
Volume | 17 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELf2ISFeEIyPBUYx0iSeMpLYzscDQtnYVCaxVqOVtqfIdmxWaU2gTSX2j_D3cuek1SL2xEse6ktS53dn39nn3xFyaDQvrUgCP4pkCQGKhXFQ2NIXWiilU4l8JJhtcREPp_z8SlxtkXUxzu4DLh8M7bCe1HRxe_T7191nMPhPmMYc8uTjeZ4ffedxnGZ8m-y6jSLM4ev8fDckM_DqcZty74F7ejOSI-7_d3i-Nz_1cyfvTUZnT8mTzoukeQv7M7Jlqj3y6Fu3T_6c_Pk6d0dCGkNlVdJRZfxrUGk6WjWgYWZJawsNNF82N3PpT-QMonZT0vHqFrRSLu7oZY_Am47bLK65obOKjlwuNQb17cOVWRo6dpnoFJd16RdcB0JKD7-p_Ql6pd2bXpDp2enkZOh3FRh8LQLewACtuZRxolINrqJGsj-hlRWBNmWMNC8qgiiUR0FkdWrKUCVxUCYQcJeMSyMZe0l2qroy-4QC5kxHNkqlsOCiwYdPoliBTBZbnmnrkcM1CsXPlmijgAAFwSoArKIDyyPHiNBGBNmx3Q_14kfRGRvmqqWJNjxJwOEKpcAgFv6MCkObaa3gIe8Q36I9arqx8SJPsV4h4zzzyAcngXoHMGvZHVaAviBfVk_yoCcJ1ql7ze_XOlRgE6a0VaZeLQsGs0zkqj175FWrU5tesYzxOMiYR9KetvW63W-pZjeOHBziWzxtzV___61vyGNAlLcLTQdkp1mszFtwvRo1INvB9RCu6Uk4ILvHpxfjy4Fbxhg4g_sL0Pk0vw |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Immediate+and+One-Year+Outcomes+of+an+Asthma-Tailored+Pulmonary+Rehabilitation+Programme+in+Overweight+and+Obese+People+with+Difficult-to-Treat+Asthma&rft.jtitle=Journal+of+asthma+and+allergy&rft.au=Ricketts%2C+Helen+Clare&rft.au=Sharma%2C+Varun&rft.au=Steffensen%2C+Femke&rft.au=Mackay%2C+Elaine&rft.date=2024-01-01&rft.pub=Dove&rft.eissn=1178-6965&rft.volume=17&rft.spage=911&rft.epage=928&rft_id=info:doi/10.2147%2FJAA.S466894&rft.externalDocID=PMC11439354 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1178-6965&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1178-6965&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1178-6965&client=summon |